Antimicrobial resistance surveillance
5 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- SEMMELWEIS EGYETEM
Hungary's leading medical university with deep expertise in mental health, complement immunology, mRNA therapeutics, and AI-driven clinical tools across 31 H2020 projects.
“AmReSu (coordinated by Semmelweis) builds next-generation sequencing networks for AMR surveillance, signaling a new research direction.”
HU31 projects - KLINIKA ZA INFEKTIVNE BOLESTI DR. FRAN MIHALJEVIC
Croatia's specialist infectious disease hospital contributing clinical research sites, AMR surveillance, and outbreak preparedness expertise to European consortia.
“AmReSu focuses on AMR surveillance with whole genome sequencing, and ECRAID-Base addresses AMR as a core infectious disease challenge.”
PrimaryHR3 projects - UNIVERSITATS-KINDERSPITAL BEIDER BASEL
Swiss university children's hospital contributing pediatric clinical expertise to European consortia on vaccines, neonatal infection prevention, and antimicrobial resistance.
“NeoIPC explicitly addresses resistance surveillance and implementation science for resistant bacterial infections.”
CH3 projects - ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL'ABRUZZO E DEL MOLISE G CAPORALE
Italian national veterinary institute specializing in animal disease surveillance, food safety diagnostics, and One Health research across Europe.
“AMR appears as a keyword in both One Health EJP and ICRAD, indicating sustained engagement with resistance monitoring.”
IT3 projects - INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE
UK national critical care audit body providing ICU real-world data infrastructure for European infectious disease and pandemic research.
“ECRAID-Base (2021-2026) explicitly names antimicrobial resistance as a focus area, extending ICNARC's infectious disease scope beyond pandemic pathogens.”
UK2 projects